CS MEDICA A/S (”CS MEDICA” or the ”Company”) was  chosen to Vitafoods Europe 2022 Innovation Tours at the Vitafoods Europe 2022 trade fair the 10-12 May 2022. CS MEDICA’s fully owned subsidiary CanNordic a/s represented the Company and showcased the CANNASEN ®CBD product line with the purpose to target new distributor agreements.

“We were proud to be selected to showcase our unique and innovative products at the Vitafoods event. We feel that our products were highlighted especially as our products represented the only medical device brand with products containing CBD. We engaged in several interesting discussions, and we found our participation very productive, especially with the global presence of different partners,” comments CEO Lone Henriksen.

At the trade fair, CanNordic was nominated as one of the most innovative companies with unique, groundbreaking ingredients, formulations and products and hence took part in the Innovation Tour 2022.  Further, CanNordic was part of the “New Product” category and participated at the live stage Vitafoods Europe 2022 new product presentations. The presentation of the CANNASEN ® CBD line, presented by CEO Lone Henriksen, was recorded on video by the live stage content team. The video is attached in this press release and can also be viewed here.

The trade fair exceeded all expectations.  The trade fair stand got an unsurpassed attention which was accomplished by overwhelmingly positive responses, few of them rendered below;

”We met at the Vitafoods expo in Geneva. Thank you for your hospitality, your samples and the information you provided on our visit. During the meeting I mentioned I would like to try the Arthritis Gel myself, because of the pain caused by knee arthritis. I have to admit the product works very well even after the first use. The pain in my knee completely disappeared plus it provides a nice cooling effect“, comments Boris Blazic from NaturaMedica d.o.o.

“In an industry filled with hundreds of products with no clinical backing, it is extremely refreshing to see CANNASEN’s focus on clinical studies and data. Based on our experience, only the clinically-backed products survive over a long time frame and CANNASEN‘s focus on clinically-backed CBD products clearly sets them apart from the majority of the industry”, comments Varun Rungta from GCCPL India (one of the BIG Pharma companies in India).

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Tags: